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1. Introduction and aims 
 
One of the main driving force towards the preparation of steroidal compounds nowadays is 
the development of novel analogs with a biological target other than a hormone receptor, and 
therefore the reduction or elimination of unwanted hormonal effects. The synthetic tools for 
achievement of the above purpose are i) the synthesis of molecules lacking the functionalities 
necessary for effective binding to the hormone receptors; ii) modification of the binding 
ability by chemical transformation of the extant functional groups; iii) steric hindrance of the 
substrate-receptor interaction by chemical substitution; iv) altering the primary stereostructure 
or the number of ring members; and v) the design of heterocyclic derivatives that are not 
recognized by the receptor protein in consequence of their specific structure or the fact that 
their geometry differs from that of the natural hormones. Furthermore, experimental results 
during the past few years have revealed that a number of natural or synthetic steroidal 
heterocycles play important roles in complex signal transduction mechanisms, and therefore 
affect the proliferation of human cancer cells without influencing the division of intact cells. 
 Based on the previous results as mentioned above, we set out to prepare novel exo-
heterocyclic steroidal derivatives containing a triazole ring. Our synthetic modifications were 
performed on ring A and ring D of the sterane skeleton, at the positions C-1, C-2, C-15, C-16 
and C-17 respectively. Furthermore, determination of the optimal reaction conditions of 1,3-
dipolar cycloadditions and investigation the influence of the alkyne substituent on the 
intermolecular ring-closures were also planned. Our aim was to confirm the structures of all 
synthetized compounds by various spectroscopic methods and to screen these triazolyl 
derivatives in vitro for their activities against a panel of human cancer cell lines. 
 
2. Experimental methods 
 
Most of the reactions were carried out in millimolar scale, and monitored by thin-layer 
chromatography. The structures of all synthetized compounds were confirmed by 
1
H and 
13
C 
NMR measurements and other spectroscopic methods (MS and in some cases IR). The crude 
products were purified by flash chromatography. 
 2 
3. Scientific results* 
 
3.1. In our initial research, 2α-azido-5α-cholestan-3-one (3), readily available from 
cholestanone (1), was subjected to intermolecular ring-closure reactions with various terminal 
acetylenes. The Cu(I)-catalyzed regioselective cycloadditions afforded exclusively 1,4-
disubstituted triazolyl derivatives (4a–j) in good yields. The catalyst was generated in situ by 
the reduction of CuSO4·5H2O with sodium ascorbate. Furthermore, an unusual solvent system 
(CH2Cl2/H2O) was applied to simplify the reaction protocol, in contrast with the generally 
used solvents (H2O/t-BuOH, THF, MeCN). Subsequently, reduction of the synthetized 2α-
triazolyl compounds (4a−j) with KBH4 resulted in two diastereomeric alcohols (5a−j and 
6a−j), which could be separated by flash chromatography (Scheme 1). 
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Scheme 1 
 
3.2. In the next stage of our work, a diastereomeric mixture of three diols (11a−c) was 
prepared from an earlier synthetized compound (3β-hydroxy-16-hydroxymethylideneandrost-
5-en-17-one, 7) in a two-step pathway. After separation of the 16β,17β isomer (11a), the 
azido group was introduced by tosylation and subsequent SN2 substitution with NaN3 to 
afford the desired steroidal azide (13) in good yield. Several D-ring-substituted androst-5-ene 
derivatives containing a triazole ring (14a−j) were synthetized by the reaction of 13 with 
                                                 
* The numbering of the compounds accords with that in the Ph.D. Thesis 
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various terminal alkynes through use of the ″click″ chemistry approach. According to our 
observation, the steroid heterocycles bearing an OH group usually proved to be more potent 
antiproliferative agents than their analogs containing an OAc group. Thus, the novel triazolyl 
derivatives (14a–j) were deacetylated in alkaline methanol to the corresponding 3β-hydroxy 
compounds (16a−j) (Scheme 2). 
 
3.3. Intermolecular [3+2] cycloadditions of the steroid azide (13) with different nitriles 
containing an electron-withdrawing group (EWG) were carried out to furnish the desired 1,5-
disubstituted steroidal tetrazoles (15a−e). It has been found that highly electrophilic nitrile 
carbon atoms (e.g. acyl cyanides, cyanoformates) and 10 mol% copper(I) catalyst 
(Cu2(OTf)2·C6H6) were required for successful addition (Scheme 2). 
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Scheme 2 
 
3.4. For the preparation of steroidal 17α-azides, estrone-3-benzyl ether (19) and 5α-androst-
2-en-17-one (20) were used as starting materials. Stereoselective reduction of the 17-keto 
group with KBH4 leading to 21 and 25 was followed by tosylation to give 22 and 26. The 
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crude products (22, 26) were then used for further nucleophilic substitution with NaN3 to 
provide the corresponding 17α-azido compounds (23, 27) (Scheme 3). 
 
3.5. The Cu(I)-catalyzed azide-alkyne cycloadditions of the isolated 17α-azido derivatives 
(23, 27) with ten different terminal acetylenes were subsequently carried out with CuI as 
catalyst (Scheme 3). 
 
3.6. It has been found that amine base additive was not required for adequate formation of 
the Cu-acetylide complex, however dipolar cycloadditions were carried out in refluxing 
solvent (40 °C) to furnish 17α-triazolyl compounds (24a−j and 28a−j). Moreover, a 
complexing ligand (PPh3) was employed in order to enhance the activity and to improve the 
solubility of the catalyst (Scheme 3). 
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3.7. An azido group was introduced onto the unconventional position 15β of 3-methoxy-
1,3,5(10),15-estratetraen-17-one (29) by the 1,4-Michael addition of in situ generated 
azoimide. Since β-substituted ketones are often susceptible to elimination and undergo facile 
transformation to the corresponding enone, azidoketone (30) was reduced with KBH4 so as to 
avoid this adverse side-reaction. The resultant cis-azidoalcohol (31) was then reacted with 
phenylacetylene under various reaction conditions in order to determine the parameters 
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(catalyst, additives, solvent, etc.) needed for optimal yields. The best conversion was found on 
the use of a catalytic amount of CuI with the simultaneous addition of PPh3 as stabilizing 
ligand and excess DIPEA as amine base (Scheme 4). 
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Scheme 4 
 
3.8. After determination of the optimal reaction conditions, an azidoalcohol (44) in the 5α-
androstane series, readily available from dehydroepiandrosterone (DEA) in a multistep 
pathway, was subjected to similar cycloadditions with different aryl-substituted acetylenes. 
This resulted in steroidal 15β-exo-triazolyl derivatives (45a−d) in yields of 70−75%, 
independently of the substituent on the alkyne dipolarophile (Scheme 5). 
 
3.9. In this particular case the isolated yields proved to be lower than usual in CuAAC. The 
lack of full conversion of the starting materials may be attributed to the OH group on C-17, 
which is cis and therefore spatially close to the azide dipole, presumably causing a crowded 
transition state in the ring closure process. Subsequent Jones oxidation of triazolyl alcohols 
(45a−d) furnished the corresponding 17-keto analogs (46a−d) in good yields (Scheme 5). 
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3.10. In a continuation of our work, the starting material applied was 17β-acetoxy-5α-androst-
1-en-3-one (50), which is readily available from stanolone acetate (48) in a two-step pathway. 
Subsequent 1,4-Michael addition of the azoimide afforded stereoselectively the corresponding 
1α-azido derivative (51), which is not surprising considering the steric bulk of the adjacent 
angular β-methyl group on C-10. The β-substituted ketone (51) was then reduced under pH-
controlled conditions to give epimeric azidoalcohols in a ratio of 5:2, and the diastereomeric 
mixture was separated by column chromatography to yield 52 and 53 (Scheme 6). 
 
3.11. Although CuAAC is generally not affected by the steric features of the alkyne and azide 
components, it has been found that the trans (52) and cis (53) azidoalcohols displayed 
considerably different behavior under similar reaction conditions. The cycloadditions of 52 
with different aryl- and cycloalkyl-substituted acetylenes furnished steroidal 1α-exo-triazolyl 
derivatives (54a−g) in yields exceeding 90%, independently of the substituents on the alkyne 
dipolarophile (Scheme 7). 
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3.12. The resultant ″click″ products (54a−g) were deacetylated in alkaline methanol to the 
corresponding 3β,17β-diols (55a−g), while the 3-keto analogs (56a−g) were also obtained by 
Jones oxidation, during which a slight formation of enone (50) was observed (Scheme 7). 
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3.13. In contrast, the reaction of the cis-azidoalcohol (53) with phenylacetylene was not 
complete even after a longer time, and the purified product (57a) was obtained in a yield of 
only 61%. Nevertheless, treatment of substrate 53 with benzoic acid propargyl ester, in which 
the aromatic ring is situated farther from the reaction center than in phenylacetylene, resulted 
in the triazolyl derivative (57b) in a higher isolated yield (83%). These results suggest that the 
intermolecular ring closure is significantly influenced by the 3α-OH group, spatially close to 
the azide dipole on C-1, and especially by the steric bulk of the alkyne substituent, which 
presumably causes a crowded transition state in the Cu(I)-catalyzed process (Scheme 8). 
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3.14. In our research, a number of novel exo-heterocyclic steroid derivatives were obtained by 
applying CuAAC, and their structures were confirmed by various spectroscopic methods (IR, 
MS, 
1
H and 
13
C NMR). 
 
3.15. The vast majority of the novel compounds were subjected to in vitro pharmacological 
studies at the Department of Pharmacodynamics and Biopharmacy. The calculated IC50 values 
revealed that several newly-prepared triazolyl derivatives (45a−c, 46a−d, 56a−g) exhibit 
substantial antiproliferative activity against malignant human cell lines. 
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